Page last updated: 2024-11-02

pantoprazole and Spasmophilia

pantoprazole has been researched along with Spasmophilia in 2 studies

Pantoprazole: 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER.
pantoprazole : A member of the class of benzimidazoles that is 1H-benzimidazole substituted by a difluoromethoxy group at position 5 and a [(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl group at position 2.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Quasdorff, M1
Mertens, J1
Dinter, J1
Steffen, HM1
Famularo, G1
Minisola, G1
Bravi, MC1
Colucci, P1
Gasbarrone, L1

Other Studies

2 other studies available for pantoprazole and Spasmophilia

ArticleYear
Recurrent hypomagnesemia with proton-pump inhibitor rechallenge.
    Annals of internal medicine, 2011, Sep-20, Volume: 155, Issue:6

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Dyspepsia; Female; Humans; Hypocalcemia; Magnesium;

2011
Tetany, hypomagnesemia, and proton-pump inhibitors.
    The American journal of medicine, 2012, Volume: 125, Issue:10

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Biomarkers; Female; Humans; Hypoparathyroidism; Magnesium;

2012